18th August 2020
Langham Hall is delighted to have supported bd-capital on their debut investment into the UK probiotics manufacturer and brand Symprove Holdings Limited. We have been appointed to provide the full suite of administration and accounting services to bd-capital.
Founded by former Advent International partner Andy Dawson and former FTSE chief executive and chairman Richard Baker, bd-capital is dedicated to investments in pan-European mid-market businesses where changing patterns of consumer behaviour and technology disruption are creating growth opportunities.
Having been setup in June 2019, Symprove marks bd-capital’s debut investment. Symprove manufactures and distributes cutting-edge probiotics products which help support the gut microbiome. This is an area of medical research that is gaining more traction as medicine seeks answers to conditions and symptoms that continue to have limited treatment options.
The fundraising was completed entirely ‘virtually’ during the Covid-19 lockdown, gaining the backing of investors from across the world, from Australia to the USA.
bd-capital were advised by Weil, Gotshal & Manges and Carey Olsen with fundraising support from Houlihan Lokey.
Langham Hall is an award-winning provider of Fund Administration, Depositary and AIFMD services to global fund managers. To hear more about how we can help, whatever the requirements, please get in touch with a member of our team.